02:44:07 EDT Fri 09 May 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
KDA Group Inc
Symbol KDA
Shares Issued 184,699,280
Close 2025-04-15 C$ 0.27
Market Cap C$ 49,868,806
Recent Sedar Documents

KDA reaches final certification phase for Medherize

2025-04-15 18:17 ET - News Release

Mr. Marc Lemieux reports

KDA GROUP REACHES FINAL CERTIFICATION PHASE FOR MEDHERIZE WITH DSQ - DOSSIER SANTE QUEBEC

KDA Group Inc. has reached the final phase in the certification process for its Medherize platform's integration with the Dossier Sante Quebec (DSQ).

Following the successful completion of the initial certification phase announced on Dec. 3, 2024, all three required development phases for the module have now been completed. On April 7, 2025, the Direction des produits de prestations de services du DSQ, through its integration and certification support team, confirmed that the final self-assessment phase was successfully passed.

The final audit is scheduled for April 22 to April 24, 2025, marking the last technical validation before full integration. The initial deployment of Medherize is planned for May 5, 2025, at the St-Sacrement Hospital Center in Quebec City, followed by a progressive rollout across other health care institutions in the province.

KDA is now the first technology provider in Quebec to successfully certify for DSQ integration using the granular data mode -- a major advancement in the transmission of clinical information.

Unlike laboratory results delivered in PDF format, which are often static and difficult to process, the granular mode enables structured, interoperable, and seamlessly integrable data within clinical systems. This model provides substantial gains in efficiency, safety, quality of care, as well as reductions in delays and human error.

"This achievement confirms our role as a pioneer in digital health. With the certification of the granular mode, the Medherize platform can now deliver an advanced and innovative technological experience, powered by structured, automated and real-time clinical data. It's a paradigm shift that positions Quebec at the forefront of connected medicine," said Yves Marmet, president and chief technology officer of Groupe Technologique KDA.

"Innovation has always been at the heart of our mission, but this milestone marks a turning point. It demonstrates not only our ability to deliver real-world solutions, but also our deep commitment to the long-term transformation of the health care system. I wish to recognize the outstanding work of our team," added Marc Lemieux, chief executive officer and chairman of the board of KDA.

KDA extends its sincere congratulations to its development team for successfully completing this crucial phase, reinforcing the corporation's position as a leading player in digital health innovation in Quebec and beyond.

About KDA Group Inc.

KDA Group is a leader in technological innovations and specialized software solutions (SaaS -- software-as-a-service) for the health care professionals' market. KDA is a corporation that offers quality products and has respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate the health care's digital transformation, and are available for the Canadian and international markets.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.